Co-Occurring EGFR S645C and EGFR L858R in a Patient with Lung Adenocarcinoma Induced Primary Resistance to Osimertinib

Approximately 10–20% of patients demonstrate primary resistance to EGFR-TKIs, and different EGFR mutations vary in sensitivity to EGFR-TKIs. We report a case of a 78-year-old male with lung adenocarcinoma that EGFR L858R (AF = 1.32%) coexisting with EGFR S645C (AF = 7.13%) in his diagnosed tissues a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Quan, Fei, Guo, Zhen, Lu, Zhongyu, Yang, Duoxia, Shi, Meiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576154/
https://www.ncbi.nlm.nih.gov/pubmed/37842288
http://dx.doi.org/10.2147/LCTT.S431252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576154/
https://www.ncbi.nlm.nih.gov/pubmed/37842288
http://dx.doi.org/10.2147/LCTT.S431252

Ejemplares similares